Kimberly-clark Buying Tylenol Maker Kenvue In $48.7 Billion Deal - Beritaja

Kimberly-Clark is buying Tylenol shaper Kenvue successful a rate and banal woody worthy about $48.7 billion, creating a monolithic user wellness equipment company.

Kenvue shareholders will person $3.50 per stock successful rate and 0.14625 Kimberly-Clark shares for each Kenvue stock held astatine closing. That amounts to $21.01 per share, based connected the closing value of Kimberly-Clark shares connected Friday.

Kimberly-Clark shareholders will ain about 54% of the mixed company. Kenvue shareholders will ain about 46%.

The mixed institution is anticipated to make 2025 yearly nett revenues of about $32 billion. Kimberly-Clark and Kenvue said that they identified about $1.9 cardinal successful costs savings that are expected successful the first 3 years aft the transaction’s closing.

“With a shared committedness to processing subject and exertion to supply bonzer care, we will service billions of consumers crossed each shape of life,” Kimberly-Clark Chairman and CEO Mike Hsu said successful a statement.

Hsu will beryllium president and CEO of the mixed company. Three members of the Kenvue’s committee will subordinate Kimberly-Clark’s committee astatine closing. The mixed institution will support Kimberly-Clark’s office successful Irving, Texas and proceed to person a important beingness successful Kenvue’s locations.

The woody is expected to adjacent successful the 2nd half of adjacent year. It still needs support from shareholders of some both companies.

Shares of Kimberly-Clark slipped much than 15% earlier the marketplace open, while Kenvue’s banal jumped much than 20%.